Reports from the
American Association for the Study of Liver Diseases
51th Annual Meeting, Dallas
Dallas, Texas, October 2000
Interferon Plus Ribivarin Combination Treatment and Impact on HIV
Infection in Hemophiliacs with Chronic HCV and Under HAART
Interferon+Ribivarin in 19 HCV/HIV Coinfected Hemophiliacs Reported at AASLD
Does Amantadine Help
Response to HCV Therapy?
Pegasys Combinations With Amantadine, Ribivarin + Amantadine, and Mycophenolate Acid
HAART, & Diabetes
What is the Association Between Diabetes & HCV & HAART?
in HCV and HCV/HIV Coinfection
Coinfected patients mount broad & strong response to HIV but not HCV.
May Improve Fibrosis, ALT, Insulin & Triglycerides in Chronic HCV
Weight Reduction In Patients With Chronic Hepatitis C Improves LIver Histology & Biochemistry
18 Months Interferon+Ribivarin Reduces Relapse Rate Compared
to 6 Months Treatment
Low Relapse Rate in Chronic Hepatitis C Treated with 18 Months Interferon-Alpha & Ribavirin as Compared to 6 Months Combination Therapy and to 18 Months Monotherapy. A Benelux Study in 300 Patients.
Hepatitis C Virus Resistance to Antiviral Therapy in PDF format only
By Jean Michel Pawlotsky
Summary of 1 Day Conference Held at NIH in
December 1999 entitled "Hepatitis C in African-Americans"
(excerpted from Gastroenterology 2000; 119: 1385-1396)
also, PDF version of entire article
Summary of the AASLD Meeting - Hepatology,
October 2000 supplement
Written for NATAP by Ray Chung, MD, Director of Transplantation, Massachusetts General Hospital, Boston
Live Reports from Dallas
Written by Jules Levin
HIV Medications & HCV at Dallas AASLD Conference: More Research Needed
Reported by Jules Levin
Histologic Patten of Liver Injury in HIV-Positive Patients on HAART: A Possible Hepatotoxic Effect of Protease Inhibitors
Hepatotoxicity Associated with Non-nucleoside Reverse Transcriptase Inhibitors for the Treatment of Human Immunodeficiency Virus and the Effect of Hepatitis B or C Virus Infection
Additional reports are being prepared and will be posted as each is finished.